title: Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data.
abstract: Acute heart failure syndromes (AHFS) are likely to increase in the future, and the high readmission rate of patients with AHFS is an important issue in Western countries. However, there are very few published epidemiological studies on AHFS in the Asia Pacific region. Because AHFS are heterogeneous, the characteristics, clinical profile, and management of AHFS should be clarified in an epidemiological study. The acute decompensated heart failure syndromes (ATTEND) registry is a prospective, observational, multicenter cohort study being performed in Japan and is the first epidemiological study of AHFS in the Asia Pacific region. This study is designed to investigate several aspects of AHFS as follows: (1) the registry allows patient-based data collection for precise evaluation of patient characteristics and short-term outcomes, including the readmission rate; (2) confirmation of clinical assessments can be performed, and new clinical assessments can be created; and (3) feedback allows the modification of guidelines for clinical management. The present report describes the clinical characteristics of patients with AHFS in Japan based on the preliminary data collected in this study, and the similarities and differences in characteristics of these patients compared with those in Western countries. Although most of the patient characteristics did not differ from those reported in Western studies, there are some unique findings in this study, including a high rate of treatment with carperitide (69.4%) and angiotensin II receptor blockers (53.9%) at discharge and a longer hospital stay (median 21 days). The ATTEND registry is designed to provide valuable information to clarify the characteristics of patients with AHFS to improve their management.
authors.affiliation: Intensive and Cardiac Care Unit, Nippon Medical School, Tokyo, Japan. nms-ns@nms.ac.jp
authors.forename: Naoki
authors.initials: N
authors.lastname: Sato
authors.forename: Katsuya
authors.initials: K
authors.lastname: Kajimoto
authors.forename: Kuniya
authors.initials: K
authors.lastname: Asai
authors.forename: Masayuki
authors.initials: M
authors.lastname: Mizuno
authors.forename: Yuichiro
authors.initials: Y
authors.lastname: Minami
authors.forename: Michitaka
authors.initials: M
authors.lastname: Nagashima
authors.forename: Koji
authors.initials: K
authors.lastname: Murai
authors.forename: Ryo
authors.initials: R
authors.lastname: Muanakata
authors.forename: Dai
authors.initials: D
authors.lastname: Yumino
authors.forename: Tomomi
authors.initials: T
authors.lastname: Meguro
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Kawana
authors.forename: Jun
authors.initials: J
authors.lastname: Nejima
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Satoh
authors.forename: Kyoichi
authors.initials: K
authors.lastname: Mizuno
authors.forename: Keiji
authors.initials: K
authors.lastname: Tanaka
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kasanuki
authors.forename: Teruo
authors.initials: T
authors.lastname: Takano
mesh_terms: D000208:Acute Disease; D000368:Aged; D045422:Continuous Positive Airway Pressure / Q000379:methods*; D004232:Diuretics / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D017052:Hospital Mortality / Q000639:trends; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D012042:Registries; D012107:Research Design; D015996:Survival Rate; D013577:Syndrome; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D004232:Diuretics; D014665:Vasodilator Agents